Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
Fibroblast growth factor technology constitutes a significant breakthrough in the treatment of metabolic and cancer-related diseases. - June 03, 2025
Press Releases 1 - 1 of 1